On April 13, 2024, accompanied by Chen Yingying, Deputy Mayor of Xinxiang City, and Ding Wenguang, Deputy Secretary of the District Committee, representatives from more than ten overseas Chinese, Chinese businesses, and organizations, including the Australia China Culture and Technology Investment Company and the German Europe China Health Promotion Association, visited Henan EMICRO Biopharmaceutical Co., Ltd.

       In the comprehensive technology building of EMICRO Biomedicine Company, visiting leaders, overseas Chinese, and Chinese representatives were warmly welcomed. The company's Chief Medical Officer Yang Yinke, Deputy General Manager Jin Jianxin, Medical Director Yu Lifang, and other leaders welcomed and received on site. Dr. Yang Yinke explained to the visiting leaders and guests about the company's Class I anti-tumor innovative drug project that has won the international cutting-edge technology award, as well as the approval to conduct Phase I clinical trials; Vice General Manager Jin Jianxin introduced the company's developed anti-tumor research and development pipeline and the situation of obtaining international scientific research patents. In a warm atmosphere, visiting leaders and overseas Chinese from all walks of life carefully watched the exhibits and medals, and listened to the introduction of the company's situation. They fully affirmed and highly praised the scientific research projects and capabilities carried out by EMICRO Biomedicine Company, and expressed their intention to strengthen communication and cooperation.